Pharmacy benefit managers, which set how drugs are covered by health insurance, have faced a decade of scrutiny from regulators and lawmakers over pricing.

FTC's July 2024 report makes unsubstantiated, false and biased claims about the PBM industry; fails to take into account the value that PBMs deliver to consumers and patients Information about Express ...

Express Scripts was the first to cap out-of-pocket costs for insulin medications at $25 for a 30-day supply in 2019, well before the government took action ST. LOUIS, Sept. 20, 2024 /PRNewswire/ -- ...

Express Scripts will partner with CPESN in the latest evolution of its IndependentRx Initiative, which aims to boost independent and community pharmacies. The pharmacy benefit manager announced ...

Express Scripts — one of the largest pharmacy benefit managers in the country — has notched a major partnership with independent pharmacies, amid contentious relations between the two industries. The ...

Cigna and Express Scripts completed their $67 billion combination in December, forming a healthcare giant with $140 billion in revenue. Express Scripts Chief Technology Officer Phil Finucane is one of ...

Express Scripts, the pharmacy benefits services business of The Cigna Group’s Evernorth, is making it easier for people to access a broader range of care services at independent pharmacies A new ...

Express Scripts is suing the Federal Trade Commission (FTC), demanding the retraction of a report it claims is false and harmful to the pharmacy benefit manager (PBM) industry. Express Scripts is ...

Express Scripts was the first to cap out-of-pocket costs for insulin medications at $25 for a 30-day supply in 2019, well before the government took action "The fact is that in the unlikely event the ...

Amid increased scrutiny from policymakers, the pharmacy benefit manager (PBM) industry is now looking to strike back through legal channels. Express Scripts, one of the biggest PBMs in the U.S., ...

FTC's July 2024 report makes unsubstantiated, false and biased claims about the PBM industry; fails to take into account the value that PBMs deliver to consumers and patients ST. LOUIS, Sept. 17, 2024 ...